Published in Women's Health Weekly, July 14th, 2005
The study of 58 breast cancer patients found that the best way to predict a patient's recurrence-free survival is to review the initial MR examination (before the patient has chemotherapy) and the final MR examination (after chemotherapy has been completed).
"Initial tumor volume was a strong predictor of recurrence-free survival. Of the women who had tumor volumes of 33 cm3 or less on the initial MR exam, 93% remained disease free after 2 years, compared with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.